Sign in

Mario van der Stelt

@mvdstelt.bsky.social
710 followers 370 following 6 posts

Professor of Molecular Physiology at Leiden University. Chemical Neurobiology & Medicinal Chemistry. Wildlife photography

PostsRepliesMedia
Mario van der Stelt @mvdstelt.bsky.social · 23/05/2026
This week in Nature Neuroscience: our study links “foamy” GPNMB⁺ microglia/macrophages, oxylipins and lipid metabolism to lesion expansion and faster progression in multiple sclerosis. MAGL emerges as a potential therapeutic target www.nature.com/articles/s41...
nature.com
Foamy microglia link oxylipins to disease progression in multiple sclerosis - Nature Neuroscience
Foamy microglia are associated with multiple sclerosis progression, linking phagocytosis, altered lipid metabolism (oxylipins) and lysosomal stress to nonclassical neuroinflammation and disease severi...
051
Mario van der Stelt @mvdstelt.bsky.social · 22/08/2025
Heading home after a fantastic cannabinoid GRC meeting organised by @drjkhokhar.bsky.social and Cecilia Hillard. Hope to see you all in Dijon ICRS-meeting June 28th -July 2nd, 2026 @icrsonbluesky.bsky.social
062
Reposted by Mario van der Stelt
Stephan Hacker @stephanhacker2.bsky.social · 02/07/2025
It also highlights work by the group of @mvdstelt.bsky.social of the @led3hub.bsky.social on profiling the targets of BIA 10-2474 (www.science.org/doi/10.1126/...) as well as the work that @mads-chem.bsky.social performed in Ben Cravatt's lab on JAK1 inhibitors (www.nature.com/articles/s41...) (4/5)
science.org
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
A drug that was unexpectedly neurotoxic in a clinical trial has off-target activities in chemical proteomic assays.
142
Reposted by Mario van der Stelt
Stephan Hacker @stephanhacker2.bsky.social · 02/07/2025
A new exciting article in @natbiotech.nature.com highlights the power of chemical proteomics to find druggable pockets on difficult high-value targets. Great insights into applications in covalent and non-covalent drug discovery including clinical development. (1/5) www.nature.com/articles/s41...
nature.com
Probing the proteome - Nature Biotechnology
Chemical proteomics has brought rigor to covalent drug discovery and drugs to the clinic. Can it deliver a new generation of drug targets?
2238
Reposted by Mario van der Stelt
Stephan Hacker @stephanhacker2.bsky.social · 10/04/2025
A great talk by Joel Rüegger of the group of @mvdstelt.bsky.social at #FocusOnCovalentDrugs. He talked about his amazing work in the @led3hub.bsky.social on the CellEKT platform for profiling target engagement of kinase inhibitors in living cells. (1/5) www.mcponline.org/article/S153...
182
Reposted by Mario van der Stelt
Stephan Hacker @stephanhacker2.bsky.social · 25/03/2025
Lipidation of proteins has diverse essential roles in biology. In his amazing keynote lecture at #Lunteren, Marc Baggelaar talked about his group's exciting contributions to better understand protein lipidations using #ChemicalProteomics. (1/5) #chemsky #ChemBio
1114
Reposted by Mario van der Stelt
Derek Lowe @dereklowe.bsky.social · 05/03/2025
Another “Continuing Crisis” post, this one covering some larger principles and explaining why I’m doing these in general:
science.org
The Continuing Crisis, Part VII: An Overview
67026
Mario van der Stelt @mvdstelt.bsky.social · 21/02/2025
Congratulations and a big thank you to @verenas.bsky.social and the labs of Istvan Katona, Yulong Li, Nephi Stella, and Laura Heitman, Coen van Hasselt at @led3hub.bsky.social and @unileiden.bsky.social for a fantastic collaboration. 4/4
051
Mario van der Stelt @mvdstelt.bsky.social · 21/02/2025
Mathematical modelling provided a comprehensive understanding of endocannabinoid signaling. The model addresses key questions in the field and suggests that microvesicles carrying signaling lipids in their membrane regulate neuronal functions in parallel to synaptic vesicles. n/3
120
Mario van der Stelt @mvdstelt.bsky.social · 21/02/2025
Our findings led us to propose an “on demand release” model, where microvesicle formation governs endocannabinoid release. This model reconciliates three previously proposed hypotheses for endocannabinoid trafficking. n/2
120
Mario van der Stelt @mvdstelt.bsky.social · 21/02/2025
Happy to announce on my first bsky post that today our manuscript “The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles” has been published in its final form in PNAS n/1
pnas.org
5183